loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 203817 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 MESALAMINE (1)

filter

01 ACTAVIS LABS FL (1)

filter

01 TABLET, DELAYED RELEASE;ORAL (1)

filter

01 1.2GM (1)

filter

01 USA (1)

URL Supplier Web Content
TABLET, DELAYED RELEAS...
1.2GM
MESALAMINE
USA
203817
2018-03-23
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 203817

Looking for CTD TGA MCC DOSSIER APPLICATION 203817 1

19

Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is MESALAMINE, with a corresponding application number 203817 and regulatory information .

proudly manufactured in the

approval since 2018-03-23

Actavis Inc's MESALAMINE TABLET, DELAYED RELEASE;ORAL, medication with 1.2GM of MESALAMINE.

Post Enquiry
POST ENQUIRY